Last reviewed · How we verify

NCT04303728

Use of Muscle Ultrasound to Predict Function

Completed NA Last updated 28 April 2022
What this trial tests

NA trial testing Muscle ultrasound in Spinal Cord Injury in 80 participants. Completed in 30 January 2022.

Timeline
1 February 2020
Primary endpoint
30 January 2022
30 January 2022

Quick facts

Lead sponsorTan Tock Seng Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment80
Start date1 February 2020
Primary completion30 January 2022
Estimated completion30 January 2022
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Tan Tock Seng Hospital

Who can join

21 and older, any sex, with Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Establish if change from the baseline in ultrasound muscle parameters over 2 months of rehabilitation correlates with functional status of SCI patients at the end of rehabilitation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Spinal cord injury: molecular mechanisms and therapeutic interventions.
    Hu X, Xu W, Ren Y, Wang Z, et al · · 2023 · cited 400× · PMID 37357239 · DOI 10.1038/s41392-023-01477-6

Verify or expand the search:

Other trials of Muscle ultrasound

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injury

Currently open trials in the same condition.

Other Tan Tock Seng Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04303728.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing